**Core Concept**
The American Brachytherapy Society (ABS) guidelines provide recommendations for the dose of radiation to be delivered to specific points in the body during brachytherapy, a type of cancer treatment that involves the placement of a radioactive source inside or next to the tumor. In the context of cervical cancer, the dose of radiation to point A is a critical parameter in determining the effectiveness of treatment.

**Why the Correct Answer is Right**
The ABS guidelines recommend a dose of 80-85 Gy at point A for early-stage cervical cancer and 85-90 Gy for locally advanced cervical cancer. This dose range is based on the need to deliver a sufficient amount of radiation to the tumor while minimizing damage to surrounding healthy tissues. The dose of radiation is typically measured in Gray (Gy), a unit of absorbed radiation dose. The specific dose range recommended by the ABS takes into account the tumor's size, location, and the patient's overall health.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it underestimates the dose of radiation required for locally advanced cervical cancer. The recommended dose for early-stage cervical cancer is 80-85 Gy, but this is not sufficient for locally advanced disease.
**Option B:** This option is incorrect because it does not accurately reflect the dose range recommended by the ABS for either early-stage or locally advanced cervical cancer.
**Option D:** This option is incorrect because it overestimates the dose of radiation required for both early-stage and locally advanced cervical cancer.

**Clinical Pearl / High-Yield Fact**
When performing brachytherapy for cervical cancer, it is essential to carefully plan the treatment to ensure that the tumor receives the recommended dose of radiation while minimizing exposure to surrounding healthy tissues. This can involve the use of imaging studies, such as CT scans or MRI, to precisely locate the tumor and surrounding structures.

**✓ Correct Answer: C. 80-85Gy- 85-90Gy**